At fifty-eight, my doctor mentioned starting hormone replacement therapy, but I want to know which delivery methods have the fewest cardiovascular risks for older women.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
At fifty-eight, my doctor mentioned starting hormone replacement therapy, but I want to know which delivery methods have the fewest cardiovascular risks for older women.
3 real searches · 1 real-search pass
menopausal hormone therapy transdermal versus oral cardiovascular risk venous thromboembolism stroke guideline 2022 NAMS age 60 10 years menopauseGoogle ↗
OBSERVED
ACOG route of administration estrogen transdermal thrombosis risk oral menopausal hormone therapyGoogle ↗
OBSERVED
Endocrine Society menopause hormone therapy cardiovascular risk transdermal women risk factors guidelineGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
menopausal hormone therapy transdermal versus oral cardiovascular risk venous thromboembolism stroke guideline 2022 NAMS age 60 10 years menopause Google ↗
ACOG route of administration estrogen transdermal thrombosis risk oral menopausal hormone therapy Google ↗
Endocrine Society menopause hormone therapy cardiovascular risk transdermal women risk factors guideline Google ↗
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- Postmenopausal Estrogen Therapy Route of Administration and Risk of Venous Thromboembolism · acog.org
- Recommendations | Menopause: identification and management | Guidance · nice.org.uk
- ACOG Clinical Practice Guideline: Management of... : Obstetrics & Gynecology · doi.org
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
menopausal hormone therapy transdermal versus oral cardiovascular risk venous thromboembolism stroke guideline 2022 NAMS age 60 10 years menopause OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ACOG route of administration estrogen transdermal thrombosis risk oral menopausal hormone therapy OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Endocrine Society menopause hormone therapy cardiovascular risk transdermal women risk factors guideline OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |